In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.

Learn how Reneo Pharmaceuticals was able to get to clinic in 14 weeks from delivery of their API with the Quick to ClinicTM for Oral Solid Dose program.